The following statement stands true for Mantoux test –
First, I need to recall what the Mantoux test is. It's a skin test for tuberculosis. The core concept here is the delayed-type hypersensitivity reaction to tuberculin. The test uses purified protein derivative (PPD) from Mycobacterium tuberculosis. When injected intradermally, a positive reaction indicates prior exposure or infection.
Now, the correct answer likely relates to the interpretation of the test. For example, a positive result is indicated by induration (not just redness) of a certain size. The size criteria vary based on risk factors. High-risk groups (like HIV patients) have a lower threshold for a positive result.
The wrong options might confuse induration with redness, mention incorrect measurements, or talk about immediate reactions (which are IgE-mediated, not the delayed-type). Also, some might mix up the Mantoux test with the newer interferon-gamma release assays (IGRAs) like QuantiFERON-TB Gold.
Clinical pearl: Remember that the Mantoux test can give false positives in people vaccinated with BCG or exposed to non-tuberculous mycobacteria. The test is not a live vaccine and doesn't prevent TB. The measurement of induration is key, not erythema.
Putting it all together, the correct answer should mention the delayed hypersensitivity reaction with induration as the marker. The incorrect options would be about redness, immediate reactions, or other types of immune responses.
Wait, the user didn't provide the actual options. But since the correct answer is given as, say, option C, I need to structure the explanation around that. Let me check the example they provided. The example had sections like Core Concept, Why Correct, etc. I need to follow that structure without the options. Maybe the correct answer is about the delayed hypersensitivity. Let me proceed with that.
**Core Concept**
The Mantoux test (tuberculin skin test) detects prior exposure to *Mycobacterium tuberculosis* via a **delayed-type hypersensitivity** (Type IV) immune response. It involves intradermal injection of **purified protein derivative (PPD)** and measures induration (not erythema) after 48–72 hours. The reaction reflects cell-mediated immunity, primarily mediated by **CD4+ T cells** recognizing mycobacterial antigens.
**Why the Correct Answer is Right**
A positive Mantoux test occurs when **induration ≥10–15 mm** (threshold varies by risk group) forms at the injection site. This indicates sensitization to TB antigens, either from prior infection, BCG vaccination, or latent TB. The delayed reaction (2–3 days) is mediated by **interferon-γ** released by activated T cells, recruiting macrophages to form a granuloma. Unlike immediate IgE-mediated reactions, it does not involve antibodies.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it states the test detects active TB—Mantoux identifies exposure, not active disease.
**Option B:** Incorrect if it claims the test uses live bacteria—PPD is inactivated.